Skip to content


  • Poster presentation
  • Open Access

Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis

  • 1, 2Email author,
  • 1, 2,
  • 1, 2,
  • 1, 2,
  • 1, 2,
  • 3,
  • 3,
  • 3,
  • 3 and
  • 1, 2
Retrovirology20107 (Suppl 1) :P24

  • Published:


  • Viral Replication
  • Proteasomal Degradation
  • Restriction Factor
  • Cytokine Receptor
  • Accessory Protein


The host restriction factor Apobec3G is a cytidine deaminase that incorporates into HIV-1 virions and interferes with viral replication. The HIV-1 accessory protein Vif subverts Apobec3G by targeting it for proteasomal degradation. We studied the Apobec3G homomerisation and the interaction of Apobec3G with Vif in detail.


We used the MAPPIT two-hybrid technique to analyse the Apobec3G-Apobec3G and the Apobec3G-Vif interactions in intact human cells. MAPPIT is based on the functional complementation of a cytokine receptor signalling pathway.


We propose a model in which Apobec3G N-terminal domains symmetrically interact via a head-to-head interface containing residues 122 RLYYFW 127. Mutations in the head-to-head interface abrogate the Apobec3G-Apobec3G interaction. All mutations that inhibit Apobec3G-Apobec3G binding also inhibit the Apobec3G-Vif interaction, indicating that the head-to head interface plays an important role in the interaction with Vif. Only the D128K, P129A and T32Q mutations specifically affect the Apobec3G-Vif association. In our model, D128, P129 and T32 cluster at the edge of the head-to-head interface, possibly forming a Vif binding site composed of two Apobec3G molecules.


We propose that Vif either binds directly at the Apobec3G head-to-head interface or associates with an RNA-stabilized Apobec3G oligomer.

Authors’ Affiliations

University of Ghent, Ghent, Belgium
VIB, Ghent, Belgium
TIBOTEC, Mechelen, Belgium


© Lavens et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.